For the Inventor, By the Inventor

Enter inventor name

Seoul, South Korea

Tae Won Choi

USPTO Granted Patents = 10 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 4(Granted Patents)

Company Filing History:

Nexgen Biotechnologies, Inc.

Inist St Co., Ltd.

University-Industry Cooperation Group of Kyung Hee University

4. 6 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2016-2023

Loading Chart...

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11786450 - Fusion protein comprising heat shock protein 10 and brazzein protein with enhanced anti-oxidation activity and skin cell proliferation effect and anti-wrinkle cosmetic composition comprising the same as effective component (2023-10-17),

2. 11166898 - Human growth hormone fusion protein with enhanced thermal stability and cosmetic composition for anti-wrinkle and maintaining skin elasticity comprising the same as effective component (2021-11-09),

3. 10815284 - Fusion protein comprising antifreeze protein and human epidermal growth factor with increased anti-oxidant activity and skin cell proliferation effect and cosmetic composition for anti-wrinkle comprising the same as effective component (2020-10-27),

4. 10441632 - Anti-wrinkle and anti-aging cosmetic composition comprising green fluorescent protein-human epidermal growth factor fusion protein as effective component (2019-10-15),

5. 10266817 - Botulinum toxin-human epidermal growth factor fusion protein with increased skin cell proliferation and anti-oxidation effect and cosmetic composition for regenerating skin and improving skin wrinkle comprising the same as effective component (2019-04-23),

6. 10125181 - Thermostable human epidermal growth factor-spider venom fusion protein with increased skin cell proliferation effect and cosmetic composition for anti-wrinkle and maintaining elasticity of skin comprising the same as effective component (2018-11-13),

7. 9956270 - Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity (2018-05-01),

8. 9919035 - Pharmaceutical composition comprising bee venom-phospholipase A2 (bv-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity (2018-03-20),

9. 9879060 - SV82 polypeptide, and cosmetic composition for reducing skin wrinkles and maintaining skin elasticity comprising SV82 polypeptide as active ingredient (2018-01-30),

10. 9526767 - Pharmaceutical composition comprising bee venom-phospholipase A2 (BV-PLA2) for treating or preventing diseases related to degradation of abnormal regulatory T cell activity (2016-12-27),

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…